These are the year's top 10 most-read muscular dystrophy news stories we published last year, each with a brief description.
A Community Event for Duchenne Muscular Dystrophy Awareness Brick, United States – January 1, 2026 / Steps for Hope 5K / The ...
Arthur Palyan, Best Life Coach California 2025, claims the self-help industry has it backwards Motivation fades. Willpower runs out. Seeing your pattern is what actually changes your life.” — Arthur ...
Myotonic dystrophy type 1 (DM1) is the most common form of adult-onset muscular dystrophy, affecting about 1 in 8,000 people. While it is well known for causing muscle weakness and stiffness, DM1 also ...
ELLSWORTH, Maine (WABI) - On Saturday, November 22, those who head to The Grand Theater in Ellsworth will get a chance to see the state of Maine in a way they’ve likely never seen before. “Seasons of ...
The family of a boy with a severe degenerative muscle disease has urged their local hospital to prescribe a drug that could help slow down the progress of the condition. Six-year-old Jack was ...
Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
Some children in Northern Ireland who live with a severe form of muscular dystrophy will be able to access new medication on the health service, BBC News understands. The move from the Belfast Health ...
Abstract: Quantitatively deciphering the relationship between muscle activation and thickness deformation is essential for diagnosing muscle-related diseases and monitoring muscle health (e.g., ...
Duchenne muscular dystrophy (DMD) is a devastating muscle disease with premature loss of ambulation 1. The disease is caused by deficiency of the sarcolemmal protein dystrophin and results in weakness ...
The U.S. Food and Drug Administration (FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational gene therapy trials for limb girdle muscular dystrophy following three ...